{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:55:23Z","timestamp":1769511323876,"version":"3.49.0"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"923","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Osteoporosis is characterised by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and consequent increase in fracture risk. It is a common condition affecting one in three women and one in 12 men, resulting in substantial morbidity, excess mortality, and health and social services expenditure. It is therefore important to develop strategies to prevent and treat osteoporosis in both men and women. This paper reviews the pathogenesis of primary and secondary osteoporosis, as well as diagnosis, investigation, and management. This should include lifestyle changes to reduce bone loss and decrease the risk of falls, the identification and treatment of secondary causes of bone loss, and specific treatment for osteoporosis. Hormone replacement therapy, raloxifene, bisphosphonates, calcium and vitamin D, calcitonin, and parathyroid hormone have all been shown to improve bone density and decrease the risk of fracture in specific situations. It is important that treatment is tailored to the individual patient, to ensure compliance and optimise the potential benefits.<\/jats:p>","DOI":"10.1136\/pmj.78.923.526","type":"journal-article","created":{"date-parts":[[2002,9,30]],"date-time":"2002-09-30T17:42:16Z","timestamp":1033407736000},"page":"526-532","source":"Crossref","is-referenced-by-count":32,"title":["Osteoporosis"],"prefix":"10.1093","volume":"78","author":[{"given":"S P","family":"Tuck","sequence":"first","affiliation":[{"name":"Musculoskeletal Unit, Freeman Hospital , Newcastle upon Tyne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M","family":"Francis","sequence":"additional","affiliation":[{"name":"University of Newcastle upon Tyne and Freeman Hospital , Newcastle upon Tyne"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,9,1]]},"reference":[{"key":"2023042417002834800_R1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-9343(91)90512-V","article-title":"Prophylaxis and treatment of osteoporosis","volume":"90","author":"Consensus Development Conference","year":"1991","journal-title":"Am J Med"},{"key":"2023042417002834800_R2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","article-title":"Hip fracture in the elderly: a worldwide projection","volume":"2","author":"Cooper","year":"1992","journal-title":"Osteoporos Int"},{"key":"2023042417002834800_R3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/91.2.71","article-title":"Management of male osteoporosis: report of the UK Consensus Group","volume":"91","author":"Eastell","year":"1998","journal-title":"Q J Med"},{"key":"2023042417002834800_R4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s001980050172","article-title":"Forearm fractures as predictors of subsequent osteoporotic fracture","volume":"9","author":"Cuddihy","year":"1999","journal-title":"Osteoporos Int"},{"key":"2023042417002834800_R5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s001980200085","article-title":"Is distal forearm fracture in men due to osteoporosis?","volume":"13","author":"Tuck","year":"2002","journal-title":"Osteoporosis Int"},{"key":"2023042417002834800_R6","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"2023042417002834800_R7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2265.1992.tb01435.x","article-title":"Risk factors for osteoporosis","volume":"36","author":"Compston","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023042417002834800_R8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2265.1993.tb00965.x","article-title":"Risk factors for osteoporosis in men","volume":"38","author":"Scane","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023042417002834800_R9","first-page":"3431","article-title":"Osteoporosis in men","volume":"84","author":"Bilezikian","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042417002834800_R10","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/rheumatology\/39.12.1312","article-title":"Novel insights into the pathogenesis of osteoporosis: the role of intrauterine programming","volume":"39","author":"Cooper","year":"2000","journal-title":"Rheumatology"},{"key":"2023042417002834800_R11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s001980170061","article-title":"Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study","volume":"12","author":"Cooper","year":"2001","journal-title":"Osteoporos Int"},{"key":"2023042417002834800_R12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/bmj.309.6956.691","article-title":"Progressive loss of bone from the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiological study","volume":"309","author":"Jones","year":"1994","journal-title":"BMJ"},{"key":"2023042417002834800_R13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/jcem-69-3-523","article-title":"Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodelling","volume":"69","author":"Stepan","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042417002834800_R14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002239900414","article-title":"Sex hormones and osteoporosis in men","volume":"62","author":"Anderson","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"2023042417002834800_R15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.7326\/0003-4819-133-12-200012190-00010","article-title":"Association of hypogonadism and oestradiol levels with bone mineral density in elderly men from the Framingham Study","volume":"133","author":"Amin","year":"2000","journal-title":"Ann Intern Med"},{"key":"2023042417002834800_R16","first-page":"219","article-title":"Low levels of oestradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study","volume":"85","author":"Barrett-Conner","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042417002834800_R17","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","article-title":"Relative contributions of testosterone and oestrogen in regulating bone reorption and formation in normal men","volume":"106","author":"Falahati-Nini","year":"2000","journal-title":"J Clin Invest"},{"key":"2023042417002834800_R18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ageing\/21.2.139","article-title":"Pathogenesis of vertebral crush fractures in men","volume":"21","author":"Baillie","year":"1992","journal-title":"Age Ageing"},{"key":"2023042417002834800_R19","first-page":"200","article-title":"Pathogenesis of vertebral crush fractures in women","volume":"87","author":"Caplan","year":"1994","journal-title":"J R Soc Med"},{"key":"2023042417002834800_R20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ard.54.1.49","article-title":"Rheumatoid arthritis, corticosteroid therapy and the risk of hip fracture","volume":"54","author":"Cooper","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"2023042417002834800_R21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women","volume":"332","author":"Cummings","year":"1995","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R22","first-page":"131","article-title":"Testosterone deficiency is common in men with hip fracture after simple falls","volume":"37","author":"Jackson","year":"1989","journal-title":"Clin Res"},{"key":"2023042417002834800_R23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(96)01440-7","article-title":"Fall-related factors and risk of hip fracture: the EPIDOS prospective study","volume":"348","author":"Dargent-Molina","year":"1996","journal-title":"Lancet"},{"key":"2023042417002834800_R24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.307.6912.1111","article-title":"Prediction of osteoporotic fractures by postural instability and bone density","volume":"307","author":"Nguyen","year":"1993","journal-title":"BMJ"},{"key":"2023042417002834800_R25","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/jbmr.5650101209","article-title":"Predictors of hip fractures in elderly men","volume":"10","author":"Poor","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2023042417002834800_R26","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJM199105093241905","article-title":"Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group","volume":"324","author":"Grisso","year":"1991","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R27","volume-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis","author":"World Health Organisation","year":"1994"},{"key":"2023042417002834800_R28","volume-title":"Osteoporosis: clinical guidelines for prevention and treatment. Update on pharmacological interventions and an algorithm for treatment","author":"Royal College of Physicians","year":"2000"},{"key":"2023042417002834800_R29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s001980050281","article-title":"An update on the diagnosis and assessment of osteoporosis with densitometry","volume":"11","author":"Kanis","year":"2000","journal-title":"Osteoporos Int"},{"key":"2023042417002834800_R30","volume-title":"Osteoporosis: clinical guidelines for prevention and treatment","author":"Royal College of Physicians","year":"1999"},{"key":"2023042417002834800_R31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1365-2265.1999.00705.x","article-title":"Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7\u201310 years","volume":"50","author":"Behre","year":"1999","journal-title":"Clini Endocrinol (Oxf)"},{"key":"2023042417002834800_R32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0300-595X(73)80047-7","article-title":"Hyperthyroidism and calcium metabolism","volume":"2","author":"Smith","year":"1973","journal-title":"Clinics in Endocrinology and Metabolism"},{"key":"2023042417002834800_R34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJM199409293311301","article-title":"A multifactorial intervention to reduce the risk of falling among elderly people living in the community","volume":"331","author":"Tinetti","year":"1994","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(98)06119-4","article-title":"Prevention of falls in the elderly trial (PROFET): a randomised controlled trial","volume":"353","author":"Close","year":"1999","journal-title":"Lancet"},{"key":"2023042417002834800_R36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0140-6736(93)92480-H","article-title":"Effect of external hip protectors on hip fractures","volume":"341","author":"Lauritzen","year":"1993","journal-title":"Lancet"},{"key":"2023042417002834800_R37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/ageing\/27.2.195","article-title":"Will elderly rest home residents wear hip protectors?","volume":"27","author":"Villar","year":"1998","journal-title":"Age Ageing"},{"key":"2023042417002834800_R38","article-title":"Hip protectors for preventing hip fractures in the elderly (Cochrane Review)","author":"Parker","year":"2001"},{"key":"2023042417002834800_R39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2125.1998.00665.x","article-title":"Management of established osteoporosis","volume":"45","author":"Francis","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"2023042417002834800_R40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5122(98)00085-1","article-title":"HRT and vit D in prevention of non-vertebral fractures in postmenopausal women: a 5 year randomized trial","volume":"31","author":"Komulainen","year":"1998","journal-title":"Maturitas"},{"key":"2023042417002834800_R41","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJM199310143291601","article-title":"The effect of postmenopausal estrogen therapy on bone density in elderly women","volume":"329","author":"Felson","year":"1993","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R42","first-page":"1","article-title":"Estrogen treatment of patients with established postmenopausal osteoporosis","volume":"76","author":"Lindsay","year":"1990","journal-title":"Obstet Gynecol"},{"key":"2023042417002834800_R43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","article-title":"Treatment of postmenopausal osteoporosis with transdermal estrogen","volume":"117","author":"Lufkin","year":"1992","journal-title":"Ann Intern Med"},{"issue":"1","key":"2023042417002834800_R44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2474-2-7","article-title":"Hormone replacement therapy and prevention of vertebral fractures: a met-analysis of randomised trials","volume":"2","author":"Torgerson","year":"2001","journal-title":"BMC Musculoskeletal Disorders"},{"key":"2023042417002834800_R45","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of non-vertebral fractures: a met-analysis of randomised trials","volume":"285","author":"Torgerson","year":"2001","journal-title":"JAMA"},{"key":"2023042417002834800_R46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"2023042417002834800_R47","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1200\/JCO.2001.19.12.3111","article-title":"Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study patients","volume":"19","author":"Lippman","year":"2001","journal-title":"J Clin Oncol"},{"key":"2023042417002834800_R48","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","article-title":"Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis","volume":"322","author":"Storm","year":"1990","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(93)90350-X","article-title":"Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy","volume":"95","author":"Harris","year":"1993","journal-title":"Am J Med"},{"key":"2023042417002834800_R51","first-page":"1","article-title":"Use of cyclical etidronate and prevention of non-vertebral fractures","volume":"36","author":"van Staa","year":"1998","journal-title":"Br J Rheumatol"},{"key":"2023042417002834800_R52","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R53","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"2023042417002834800_R54","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"2023042417002834800_R55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03339822","article-title":"Therapeutic equivalence of alendronate 70mg once-weekly and alendronate 10mg daily in the treatment of osteoporosis","volume":"12","author":"Schnitzer","year":"2000","journal-title":"Ageing Clinical and Experimental Research"},{"key":"2023042417002834800_R56","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomised control trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"2023042417002834800_R57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established osteoporosis","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"key":"2023042417002834800_R58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R59","first-page":"3011","article-title":"Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60","volume":"85","author":"Peacock","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042417002834800_R60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00298497","article-title":"Annual injection of vitamin D and fractures of aged bones","volume":"51","author":"Heikinheimo","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"2023042417002834800_R61","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-124-4-199602150-00003","article-title":"Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial","volume":"124","author":"Lips","year":"1996","journal-title":"Ann Intern Med"},{"key":"2023042417002834800_R62","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","article-title":"Vitamin D3 and calcium to prevent hip fractures in elderly women","volume":"327","author":"Chapuy","year":"1992","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R63","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.308.6936.1081","article-title":"Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women","volume":"308","author":"Chapuy","year":"1994","journal-title":"BMJ"},{"key":"2023042417002834800_R64","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","article-title":"Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age and older","volume":"337","author":"Dawson-Hughes","year":"1997","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R65","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.305.6853.556","article-title":"Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study","volume":"305","author":"Overgaard","year":"1992","journal-title":"BMJ"},{"key":"2023042417002834800_R66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0169-6009(92)90883-F","article-title":"Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome","volume":"16","author":"Rico","year":"1992","journal-title":"Bone and Mineral"},{"key":"2023042417002834800_R67","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomised trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group","volume":"109","author":"Chestnut CH","year":"2000","journal-title":"Am J Med"},{"key":"2023042417002834800_R68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/qjmed\/92.3.143","article-title":"Effect of calcitonin on vertebral and other fractures","volume":"92","author":"Kanis","year":"1999","journal-title":"Q J Med"},{"key":"2023042417002834800_R69","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/17453674.1997.11744761","article-title":"Pain relief from salmon calcitonin in osteoporotic vertebral crush fractures. A double blind placebo-controlled clinical study","volume":"275","author":"Lyritis","year":"1997","journal-title":"Acta Orthop Scand"},{"key":"2023042417002834800_R70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jbmr.5650070110","article-title":"Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone","volume":"7","author":"Hock","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2023042417002834800_R71","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(76)92216-9","article-title":"The anabolic effects of low doses of human parathyroid hormone fragment on the skeleton in postmenopausal osteoporosis","volume":"i","author":"Reeve","year":"1976","journal-title":"Lancet"},{"key":"2023042417002834800_R72","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R73","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1210\/jcem.86.9.7847","article-title":"Effects of calcitriol or calcium on bone mineral density, bone turnover and fractures in men with primary osteoporosis: a two year randomised, double blind, double placebo study","volume":"86","author":"Ebeling","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042417002834800_R74","first-page":"261","article-title":"Cyclical etidronate in the management of osteoporosis in men","volume":"9","author":"Francis","year":"1998","journal-title":"Reviews in Contemporary Pharmacotherapy"},{"key":"2023042417002834800_R75","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate treatment of osteoporosis in men","volume":"343","author":"Orwoll","year":"2000","journal-title":"N Engl J Med"},{"key":"2023042417002834800_R76","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1210\/jcem.86.11.7988","article-title":"Alendronate treatment of established primary osteoporosis in men: results of a 2 year prospective study","volume":"86","author":"Ringe","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042417002834800_R77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1359\/jbmr.1997.12.3.472","article-title":"Androgen supplementation in eugonadal men with osteoporosis\u2014effects of six months\u2019 treatment on markers of bone formation and resorption","volume":"12","author":"Anderson","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2023042417002834800_R78","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archinte.1996.00440100065008","article-title":"Testosterone therapy in glucocorticoid-treated men","volume":"156","author":"Reid","year":"1996","journal-title":"Arch Intern Med"},{"key":"2023042417002834800_R79","first-page":"3069","article-title":"Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers","volume":"85","author":"Kurland","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042417002834800_R80","first-page":"S13","article-title":"Recombinant human parathyroid hormone (1\u201334) therapy increases bone mineral density and may decrease the risk of fractures in men with low bone density","volume":"12","author":"Kaufman","year":"2001","journal-title":"Osteoporos Int"},{"key":"2023042417002834800_R81","volume-title":"Fundementals of bone densitometry\u2014report of a working party","author":"National Osteoporosis Society","year":"1998"},{"key":"2023042417002834800_R82","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.283.10.1318","article-title":"Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group","volume":"283","author":"Cummings","year":"2000","journal-title":"JAMA"},{"key":"2023042417002834800_R83","first-page":"1","article-title":"Bone turnover markers for monitoring antiresorptive therapy","volume":"9","author":"Eastell","year":"2001","journal-title":"Osteoporosis Review"},{"key":"2023042417002834800_R84","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s001980070004","article-title":"Preanalytical variability of biochemical markers of bone turnover","volume":"11","author":"Hannon","year":"2000","journal-title":"Osteoporos Int"},{"key":"2023042417002834800_R85","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","article-title":"A unitary model for involutional osteoporosis: oestrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in ageing men","volume":"13","author":"Riggs","year":"1998","journal-title":"J Bone Miner Res"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/78\/923\/526\/50041210\/postgradmedj-78-526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/78\/923\/526\/50041210\/postgradmedj-78-526.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T17:02:04Z","timestamp":1682355724000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/78\/923\/526\/7045879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,1]]},"references-count":85,"journal-issue":{"issue":"923","published-online":{"date-parts":[[2002,9,1]]},"published-print":{"date-parts":[[2002,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pmj.78.923.526","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2002,9]]},"published":{"date-parts":[[2002,9,1]]}}}